Capecitabine (Xeloda&unknown;) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma

Author： Twelves C.   Boyer M.   Findlay M.   Cassidy J.   Weitzel C.   Barker C.   Osterwalder B.   Jamieson C.   Hieke K.   on behalf of the Xeloda  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.5, 2001-03, pp. : 597-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase III Study of Recombinant Interleukin-2, 5-Fluorouracil and Leucovorin Versus 5-Fluorouracil and Leucovorin in Patients with Unresectable or Metastatic Colorectal Carcinoma

By Heys S.D.   Eremin O.   Ruggeri E.M.   Pein F.   Rainer H.   Oskam R.   de Peuter R.A.   Palmer P.A.   Franks C.R.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon- -2c in patients with advanced colorectal cancer: final results of a randomised phase III study

By Hausmaninger H.   Moser R.   Samonigg H.   Mlineritsch B.   Schmidt H.   Pecherstorfer M.   Fridrik M.   Kopf C.   Nitsche D.   Kaider A.   Ludwig H.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer - a randomised phase II-III trial of the EORTC Gastrointestinal Group

By Wils J.   Blijham G.H.   Wagener T.   De Greve J.   Jansen R.L.H.   Kok T.C.   Nortier J.W.R.   Bleiberg H.   Couvreur M.L.   Genicot B.   Baron B.   on behalf of the EORTC Gastrointestinal Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 346-352

Elsevier

Access to resources Recommend Favorite

Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials

By                

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

By Goto Ayumu   Yamada Yasuhide   Hosokawa Ayumu   Ura Takashi   Arai Tatsuhiro   Hamaguchi Tetsuya   Muro Kei   Shimada Yasuhiro   Shirao Kuniaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite